To overcome the many challenges posed by the use of viral vectors (High development and manufacturing costs, production scale up complexity, immunogenicity and genotoxicity risks...), we are developing a unique DNA vector to reduce the cost and improve efficiency of gene therapy.
Indeed, Fabmid develops a DNA vector both easy to produce and with all the properties required from a good vector: high cell transfection efficiency, low toxicity, high stability and selectivity.
Company Details
- Employees
- 1
- Founded
- 2020
- Address
- 4 Rue Pierre Fontaine, Campus 3 Génopole Pépinière 91058 Evry Cedex, France, Evry,france
- Industry
- Biotechnology
- Website
- https://www.fabmid.com
- Keywords
- Da Volterra.
- HQ
- Evry
Fabmid Questions
Fabmid's website is https://www.fabmid.com
Fabmid's LinkedIn profile is https://fr.linkedin.com/company/fabmid-biotech
Fabmid has
1 employees.
View email and phone details for 1
employees at Fabmid.
Fabmid's industry is
Biotechnology
Fabmid's top competitors are
Imescia,
Biotechstudio,
Adaptive Phage Therapeutics,
Technophage, Sa,
Cytophage Technologies Ltd.,
Da Volterra,
Iltoo Pharma,
France Bioproduction Congress,
Eukarÿs,
Phageguard.
Fabmid's categories are Biotechnology
Fabmid's founding year is 2020
